Advertisement

Topics

Treatment with biosimilar drug improves progression-free survival in breast cancer patients

07:31 EST 1 Dec 2016 | News-Medical.net

Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.

Original Article: Treatment with biosimilar drug improves progression-free survival in breast cancer patients

NEXT ARTICLE

More From BioPortfolio on "Treatment with biosimilar drug improves progression-free survival in breast cancer patients"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...